KR19990022531A - Ｇ-단백질 수용체 ｈｔｎａｄ２９ - Google Patents

Ｇ-단백질 수용체 ｈｔｎａｄ２９ Download PDF

Info

Publication number
KR19990022531A
KR19990022531A KR1019970709012A KR19970709012A KR19990022531A KR 19990022531 A KR19990022531 A KR 19990022531A KR 1019970709012 A KR1019970709012 A KR 1019970709012A KR 19970709012 A KR19970709012 A KR 19970709012A KR 19990022531 A KR19990022531 A KR 19990022531A
Authority
KR
South Korea
Prior art keywords
polypeptide
receptor
protein
polynucleotide
dna
Prior art date
Application number
KR1019970709012A
Other languages
English (en)
Korean (ko)
Inventor
위 리
레베카 에이 풀드너
Original Assignee
벤슨 로버트 에이치.
휴먼 게놈 사이언시즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 벤슨 로버트 에이치., 휴먼 게놈 사이언시즈, 인코포레이티드 filed Critical 벤슨 로버트 에이치.
Publication of KR19990022531A publication Critical patent/KR19990022531A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
KR1019970709012A 1995-06-06 1995-06-06 Ｇ-단백질 수용체 ｈｔｎａｄ２９ KR19990022531A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007288 WO1996039442A1 (fr) 1995-06-06 1995-06-06 Htnad29 recepteurs de proteines g

Publications (1)

Publication Number Publication Date
KR19990022531A true KR19990022531A (ko) 1999-03-25

Family

ID=22249278

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970709012A KR19990022531A (ko) 1995-06-06 1995-06-06 Ｇ-단백질 수용체 ｈｔｎａｄ２９

Country Status (7)

Country Link
EP (1) EP0832126A4 (fr)
JP (1) JPH11506341A (fr)
KR (1) KR19990022531A (fr)
CN (1) CN1147505C (fr)
AU (1) AU714642B2 (fr)
CA (1) CA2221706A1 (fr)
WO (1) WO1996039442A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221627B1 (en) 1997-02-24 2001-04-24 Smithkline Beecham Corporation cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US6733990B1 (en) 1999-08-03 2004-05-11 Millennium Pharmaceuticals, Inc. Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like family
EP2264068A1 (fr) * 1998-10-13 2010-12-22 Arena Pharmaceuticals, Inc. Récepteurs non-endogènes de la protéine G humaine ayant une activité constitutive
US6919176B2 (en) 2001-05-07 2005-07-19 Amgen Inc. Polypeptides and nucleic acids associated with cancer
AU2003206749A1 (en) * 2002-02-01 2003-09-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with the gpr65 receptor
MXPA05013721A (es) 2003-06-20 2006-03-08 Novartis Ag Receptores acoplados con proteina-g de deteccion de protones, y secuencias de adn de los mismos.
WO2008101354A1 (fr) * 2007-02-22 2008-08-28 Merck Frosst Canada Ltd Gpr65 utilisé comme cible thérapeutique dans une inflammation allergique des voies respiratoires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262529A (en) * 1990-01-24 1993-11-16 President And Fellows Of Harvard College Diagnosis of hereditary retinal degenerative diseases
US5462856A (en) * 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
JPH06511386A (ja) * 1991-10-01 1994-12-22 アメリカ合衆国 リガンドおよびリガンドのアンタゴニストを同定する方法
US5508384A (en) * 1992-09-10 1996-04-16 New York University Polypeptide derived from a popamine receptor, and compositions and methods thereof
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders

Also Published As

Publication number Publication date
EP0832126A4 (fr) 2000-01-12
CA2221706A1 (fr) 1996-12-12
JPH11506341A (ja) 1999-06-08
AU2820495A (en) 1996-12-24
EP0832126A1 (fr) 1998-04-01
CN1147505C (zh) 2004-04-28
CN1193980A (zh) 1998-09-23
WO1996039442A1 (fr) 1996-12-12
AU714642B2 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
US5750370A (en) Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor
EP1007670B1 (fr) Deux recepteurs couples par des proteines g: gpcr2 induit par veb (ebi-2) et gpcr de type gde-1
US20080241124A1 (en) Human G-Protein Chemokine Receptor (CCR5) HDGNR10
US5817477A (en) Adrenergic receptor
US20050214281A1 (en) G-protein coupled receptor
US5756309A (en) Nucleic acid encoding a human G-protein receptor HPRAJ70 and method of producing the receptor
US5861272A (en) C5A receptor
US6372891B1 (en) Human G-protein receptor HPRAJ70
US20060148708A1 (en) C5a receptor
KR19990022531A (ko) Ｇ-단백질 수용체 ｈｔｎａｄ２９
WO1997024929A1 (fr) Recepteur couple de la proteine g humaine
US5869632A (en) Human G-protein receptor HCEGH45
US20050123998A1 (en) C5a receptor
US20110112177A1 (en) Human G-Protein Coupled Receptor (HETGQ23)
US7393650B2 (en) Method of producing an antibody to G-protein parathyroid hormone receptor HLTDG74
US20050059114A1 (en) G-protein receptor HTNAD29
US20080312178A1 (en) Human G-Protein Receptor HGBER32
CA2220978A1 (fr) Recepteur couple de proteines g humaines (hetgq23)
US20050266522A1 (en) Human amine receptor
AU760468B2 (en) G-protein receptor HTNAD29
US20030054487A1 (en) Human G-protein coupled receptor
US20020106734A1 (en) Adrenergic receptor
US20060014243A1 (en) Human G-protein chemokine receptor HSATU68
KR19990022378A (ko) 사람 ｇ-단백질 결합된 수용체(ｈｅｔｇｑ23)
EP0832123A1 (fr) Recepteur hltdg74 de l'hormone parathyroidienne (hpt) couple a la proteine g

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application